(St. Louis Inno) Danforth Center's new startup development subsidiary launches its first company

Danforth Technology Company (DTC), a Donald Danforth Plant Science Center subsidiary that facilitates early-stage development of startup companies based on Danforth Center technologies, has announced the creation of its first company, Peptyde Bio Inc.  Peptyde Bio is co-founded by Danforth Center Principal Investigators Dilip Shah, PhD, and Kirk Czymmek, PhD. 

“One of the advantages of this technology is it is clean, natural technology and we demonstrated that these antimicrobial peptides can be as effective as the chemicals that are used today,” said Tom Laurita, CEO of DTC and interim CEO of Peptyde Bio.